Contact us to add description.
Elsie Biotechnologies is discovering oligonucleotide therapeutics to treat undruggable diseases. Inspired by Rosalind Elsie Franklin, Elsie is pioneering in DNA and RNA technologies through the use of their three dimensional platform that allows the synthesis, deconvolution and delivery of oligonucleotide therapeutics. Elsie’s platform includes their ROSALIND discovery engine, an oligomer level rapid chemical evolution through empirical screening of all chemical space and denote conjugation chemistry designed to deliver oligomers to the liver. With this approach, Elsie is increasing the potency, decreasing the toxicity and optimizing the delivery speed of oligonucleotide therapeutics.